Drug Profile
NS 3034
Latest Information Update: 20 Jan 2017
Price :
$50
*
At a glance
- Originator NeuroSearch
- Class
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 19 Jan 2017 Discontinued - Preclinical for Stroke in Denmark
- 28 Oct 1997 Suspended-Preclinical for Stroke in Denmark (Unknown route)
- 11 Aug 1995 New profile